professional

Over the course of my 40+ year career in intellectual property and biotechnology patent law, I have authored a widely-used book, as well as many articles at the edge of science and law. Here are a few selected ones:

Goldstein, Jorge, "Waiving Covid-19 Vaccine Patents Won't Solve the Global Need," Bloomberg Industry Group News, August 6, 2021

Read it

Goldstein, Jorge, U.S. Biotechnology Patent Law. Cases and Comments for Beginning and Experienced Practitioners. Thomson Reuters, 9th edition, 2024-2025

2023 Edition

Jorge A. Goldstein, “Protecting rainforest-derived technology equitably,” WIPO Magazine, February 2019.

Read it

Jorge A. Goldstein and Michael B. Ray, "The State of The IP Boutique," LAW360 April 3 and 4, 2017.

Read it

Jorge A. Goldstein and Neil Shull, “A Post-Lexmark Plan for Multiple Inventive Methods of Use,” Law 360, 2017.

Read it

Goldstein, J., Holoubek, M., and Thakker, K. "The Time Has Come To Amend 35 U.S.C. § 101," 44 AIPLA Quarterly Journal (2) 171, 2016

Read it

Jorge A. Goldstein, "Capturing After-Discovered Embodiments in Biotechnology Patents," 25 Federal Circuit Bar J. (3) 401, 2016.

Read it

Goldstein J.A. (2015) "Sobre Genes Aislados y Enlaces Covalentes: Un Recuerdo Personal de Myriad Genetics," Revista Iberoamericana De La Propiedad Intelectual, (5), 97-107. Recovered from https://ojs.austral.edu.ar/index.php/ripi/article/view/435.

Read it

Jorge Goldstein, "AbbVie Deutschland and Unknown Embodiments: Has the Written Description Requirement for Antibodies Gone Too Far?" Bloomberg BNA, Life Sciences Law & Industry Report, April 2015. (Reproduced in BNA's P.T.C. Journal, May 2015)

Read it

Chenghua Luo and Jorge Goldstein, "Patenting Purified Natural Products by Specific Activity: Eligibility and Enablement," Bloomberg BNA Life Sciences Law and Industry Report, May 2015.

Read it

Jorge A. Goldstein, "Of Isolated Genes and Covalent Bonds: A Personal Memoir of Myriad Genetics," IP Today, April 2015, page 10.

Read it

Ebersole, T., Guthrie, M, and Goldstein, J.A. "Patent Pools as a Solution to the Licensing Problems of Diagnostic Genetics," IP and Technology Law Journal, January 2005.

Read it

Jorge A. Goldstein, "Copyrightability Of Genetic Works," Bio/Tech. 2(2): 138-142 (1984).

Read it

professional

Over the course of my 40+ year career in intellectual property and biotechnology patent law, I have authored a widely-used book, as well as many articles at the edge of science and law. Here are a few selected ones:

Goldstein, Jorge, "Waiving Covid-19 Vaccine Patents Won't Solve the Global Need," Bloomberg Industry Group News, August 6, 2021

Goldstein, Jorge, U.S. Biotechnology Patent Law. Cases and Comments for Beginning and Experienced Practitioners. Thomson Reuters, 9th edition, 2024-2025

Jorge A. Goldstein, “Protecting rainforest-derived technology equitably,” WIPO Magazine, February 2019.

Jorge A. Goldstein and Michael B. Ray, "The State of The IP Boutique," LAW360 April 3 and 4, 2017.

Jorge A. Goldstein and Neil Shull, “A Post-Lexmark Plan for Multiple Inventive Methods of Use,” Law 360, 2017.

Goldstein, J., Holoubek, M., and Thakker, K. "The Time Has Come To Amend 35 U.S.C. § 101," 44 AIPLA Quarterly Journal (2) 171, 2016

Jorge A. Goldstein, "Capturing After-Discovered Embodiments in Biotechnology Patents," 25 Federal Circuit Bar J. (3) 401, 2016.

Goldstein J.A. (2015) "Sobre Genes Aislados y Enlaces Covalentes: Un Recuerdo Personal de Myriad Genetics," Revista Iberoamericana De La Propiedad Intelectual, (5), 97-107. Recovered from https://ojs.austral.edu.ar/index.php/ripi/article/view/435.

Jorge Goldstein, "AbbVie Deutschland and Unknown Embodiments: Has the Written Description Requirement for Antibodies Gone Too Far?" Bloomberg BNA, Life Sciences Law & Industry Report, April 2015. (Reproduced in BNA's P.T.C. Journal, May 2015)

Chenghua Luo and Jorge Goldstein, "Patenting Purified Natural Products by Specific Activity: Eligibility and Enablement," Bloomberg BNA Life Sciences Law and Industry Report, May 2015.

Jorge A. Goldstein, "Of Isolated Genes and Covalent Bonds: A Personal Memoir of Myriad Genetics," IP Today, April 2015, page 10.

Ebersole, T., Guthrie, M, and Goldstein, J.A. "Patent Pools as a Solution to the Licensing Problems of Diagnostic Genetics," IP and Technology Law Journal, January 2005.

Jorge A. Goldstein, "Copyrightability Of Genetic Works," Bio/Tech. 2(2): 138-142 (1984).

© 2025 Jorge A. Goldstein.

Privacy Policy

professional

Over the course of my 40+ year career in intellectual property and biotechnology patent law, I have authored a widely-used book, as well as many articles at the edge of science and law. Here are a few selected ones:

Goldstein, Jorge, "Waiving Covid-19 Vaccine Patents Won't Solve the Global Need," Bloomberg Industry Group News, August 6, 2021

Goldstein, Jorge, U.S. Biotechnology Patent Law. Cases and Comments for Beginning and Experienced Practitioners. Thomson Reuters, 9th edition, 2024-2025

​Jorge A. Goldstein, “Protecting rainforest-derived technology equitably,” WIPO Magazine, February 2019.

Jorge A. Goldstein and Michael B. Ray, "The State of The IP Boutique," LAW360 April 3 and 4, 2017.

Jorge A. Goldstein and Neil Shull, “A Post-Lexmark Plan for Multiple Inventive Methods of Use,” Law 360, 2017.

Goldstein, J., Holoubek, M., and Thakker, K. "The Time Has Come To Amend 35 U.S.C. § 101," 44 AIPLA Quarterly Journal (2) 171, 2016

Jorge A. Goldstein, "Capturing After-Discovered Embodiments in Biotechnology Patents," 25 Federal Circuit Bar J. (3) 401, 2016.

Goldstein J.A. (2015) "Sobre Genes Aislados y Enlaces Covalentes: Un Recuerdo Personal de Myriad Genetics," Revista Iberoamericana De La Propiedad Intelectual, (5), 97-107. Recovered from https://ojs.austral.edu.ar/index.php/ripi/article/view/435.

Jorge Goldstein, "AbbVie Deutschland and Unknown Embodiments: Has the Written Description Requirement for Antibodies Gone Too Far?" Bloomberg BNA, Life Sciences Law & Industry Report, April 2015. (Reproduced in BNA's P.T.C. Journal, May 2015)

Chenghua Luo and Jorge Goldstein, "Patenting Purified Natural Products by Specific Activity: Eligibility and Enablement," Bloomberg BNA Life Sciences Law and Industry Report, May 2015.

Jorge A. Goldstein, "Of Isolated Genes and Covalent Bonds: A Personal Memoir of Myriad Genetics," IP Today, April 2015, page 10.

​Ebersole, T., Guthrie, M, and Goldstein, J.A. "Patent Pools as a Solution to the Licensing Problems of Diagnostic Genetics," IP and Technology Law Journal, January 2005.

Jorge A. Goldstein, "Copyrightability Of Genetic Works," Bio/Tech. 2(2): 138-142 (1984).

Jorge A. Goldstein, “Protecting rainforest-derived technology equitably,” WIPO Magazine, February 2019.

Ebersole, T., Guthrie, M, and Goldstein, J.A. "Patent Pools as a Solution to the Licensing Problems of Diagnostic Genetics," IP and Technology Law Journal, January 2005.